Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis: A possible mechanism for Alzheimer's disease

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2333-2340

  Yaar, Mina ^a   Zhai, Sen ^a   Pilch, Paul F ^a   Doyle, Sineaid M ^a   Eisenhauer, Patricia B ^b   Fine, Richard E ^a,b   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Melanocytes; Nerve growth factor; Neurodegenerative; Neurons; Receptor binding

Indexed keywords

AMYLOID BETA PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEMENTIA; DNA STRAND BREAKAGE; MELANOCYTE; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0030723983     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119772     Document Type: Article

References (58)

1. Yamazaki, T., D.J. Selkoe, and E.H. Koo. 1995. Trafficking of cell surface β-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J. Cell Biol. 129:431-442.
2. Barinaga, M. 1995. Missing Alzheimer's gene found. Science (Wash. DC). 269:917-918.
3. Levy-Lahad, E., E.M. Wijsman, E. Nemens, L. Anderson, K.A.B. Goddard, J.L. Weber, T.D. Bird, and G.D. Schellenberg. 1995. A familial Alzheimer's disease locus on Chromosome I. Science (Wash. DC). 269:970-972.
4. Selkoe, D.J. 1991. The molecular pathology of Alzheimer's disease. Neuron. 6:487-498.
5. Glenner, G.G., and C.W. Wong. 1993. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890.
6. Woolf, N.J., E. Gould, and L.L. Butcher. 1989. Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience. 30:143-152.
7. Bauer, J., M. Hull, and M. Berger. 1995. Pathogenetic factors of Alzheimer disease. Z. Gerontol. Geriatr. 28:155.
8. Feinstein, E., A. Kimchi, D. Wallach, M. Boldin, and E. Varfolomeev. 1995. The death domain: a module shared by proteins with diverse cellular functions [letter]. Trends Biochem. Sci. 20:342-344.
9. Boldin, M.P., E.E. Varfolomeev, Z. Pancer, I.L. Mett, J.H. Camonis, and D. Wallach. 1995. A novel protein mat interacts with the death domain of Fas/ APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795-7798.
10. Casaccia-Bonnefil, P., B.D. Carter, R.T. Dobrowsky, and M.V. Chao. 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature (Lond.). 383:716-719.
11. Frade, J.M., A. Rodríguez-Tébar, and Y.A. Barde. 1996. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature (Lond.). 383:166-168.
12. Rabizadeh, S., C.M. Bitler, L.L. Butcher, and D.E. Bredesen. 1994. Expression of the low affinity nerve growth factor receptor enhances β-amyloid peptide toxicity. Proc. Natl. Acad. Sci. USA. 91:10703-10706.
13. Yaar, M., M.S. Eller, P. DiBenedetto, W.R. Reenstra, S. Zhai, T. McQuaid, M. Archambault, and B.A. Gilchrest. 1994. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J. Clin. Invest. 94:1550-1562.
14. Peacocke, M., M. Yaar, C.P. Mansur, M.V. Chao, and B.A. Gilchrest. 1988. Induction of nerve growth factor receptors on cultured human melanocytes. Proc. Natl. Acad. Sci. USA. 85:5282-5286.
15. Gray, C.W., and A.J. Patel. 1995. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res. 691:169-179.
16. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
17. Waugh, S.M., E.E. DiBella, and P.F. Pilch. 1989. Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding. Biochemistry. 28:3448-3455.
18. Baldwin, A.N., and E.M. Shooter. 1995. Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel N-glycosylation sites. J. Biol. Chem. 270:4594-4602.
19. Mahadeo, D., L. Kaplan, M.V. Chao, and B.L. Hempstead. 1994. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J. Biol. Chem. 269:6884-6891.
20. Boland, K., M. Behrens, D. Choi, K. Manias, and D.H. Perlmutter. 1996. The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide. J. Biol. Chem. 271:18032-18044.
21. Selkoe, D.J. 1994. Normal and abnormal biology of the beta-amyloid precursor protein. Ann. Rev. Neurosci. 17:489-517.
22. Davis-Salinas, J., and W.E. Van Nostrand. 1995. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270:20887-20890.
23. Pike, C.J., D. Burdick, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1676-1687.
24. Behl, C., J.B. Davis, R. Lesley, and D. Schubert. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:817-827.
25. Cotman, C.W., and A.J. Andersen. 1995. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:19-45.
26. Su, J.H., A.J. Andersen, B.J. Cummings, and C.W. Cotman. 1994. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 5:2529-2533.
27. Behl, C., J.B. Davis, P.G. Klier, and D. Shubert. 1994. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res. 645:253-264.
28. Gschwind, M., J.R. Martin, J.L. Moreau, and G. Huber. 1996. Beta-APP cognitive function versus beta-amyloid-induced cell death. Ann. NY Acad. Sci. 77:293-296.
29. Crowley, C., S.D. Spencer, M.C. Nishimura, K.S. Chen, S. Pitts-Meek, M.P. Armanini, L.H. Ling, S.B. MacMahon, D.L. Shelton, A.D. Levinson, and H.S. Phillips. 1994. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 76:1001-1011.
30. Deckwerth, T.L., and E.M. Johnson, Jr. 1993. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123:1207-1222.
31. Selkoe, D.J. 1996. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:18295-18298.
32. Nagata, S., and P. Goldstein. 1995. The fas death factor. Science (Wash. DC). 267:1449-1456.
33. Goldstein, R.S., C. Avivi, and R. Geffen. 1997. In vivo NGF treatment increases proliferation on the primary sympathetic ganglia of chick embryos. Dev. Biol. 181:116-120.
34. Cortazzo, M.H., E.S. Kassis, K.A. Sproul, and N.F. Schor. 1996. Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor. J. Neurosci. 16:3895-3899.
35. Battleman, D.S., A.I. Geller, and M.V. Chao. 1993. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J. Neurosci. 13:941-951.
36. Chao, M.V., and B.L. Hempstead. 1995. p75 and Trk: a two-receptor system. Trends Neurosci. 19:321-326.
37. Ruit, K.G., P.A. Osborne, R.E. Schmidt, E.M. Johnson, Jr., and W.D. Snider. 1990. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J. Neurosci. 10:2412-2419.
38. Manfridi, A., G.L. Forloni, E. Arrigoni-Martelli, and M. Mancia. 1992. Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-L-carnitine and NGF. Inter. J. Develop. Neurosci. 10:321-329.
39. Jiang, Z.G., and R.A. Smith. 1993. Effects of nerve growth factor on the survival of primary cultured adult and aged mouse sensory neurons. J. Neurosci. Res. 35:29-37.
40. Cheng, B., and M.P. Mattson. 1992. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp. Neurol. 117:114-123.
41. Cheng, B., and M.P. Mattson. 1991. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 7:1031-1041.
42. Kawaja, M.D., M.B. Rosenberg, K. Yoshida, and F.H. Gage. 1992. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J. Neurosci. 12: 2849-2864.
43. Henderson, T.A., R.W. Rhoades, C.A. Bennett-Clarke, P.A. Osborne, E.M. Johnson, and M.F. Jacquin. 1993. NGF augmentation rescues trigeminal ganglion and principalis neurons, but not brainstem or cortical whisker patterns, after infraorbital nerve injury at birth. J. Comparative Neurol. 336:243-260.
44. Tuszynski, M.H., H.S. U, D.G. Amaral, and F.H. Gage. 1990. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10:3604-3614.
45. Shimohama, S., N. Ogawa, Y. Tamura, A. Akaike, T. Tsukahara, H. Iwata, and J. Kimura. 1993. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res. 632: 296-302.
46. Seiger, A., A. Nordberg, H. von Holst, L. Backman, T. Ebendal, I. Alafuzoff, K. Amberla, P. Hartvig, A. Herlitz, A. Lilija, et al. 1993. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res. 57:255-261.
47. Lapchak, P.A. 1993. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol. 124:16-20.
48. Olson, L., A. Nordberg, H. von Holst, L. Backman, T. Ebendal, I. Alafuzoff, K. Amberla, P. Hartvig, A. Herlitz, A. Lilija, et al. 1992. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J. Neural. Transm. Parkinson's Dis. Dementia. Sect. 4:79-95.
49. Zhai, S., M. Yaar, S. Doyle, and B.A. Gilchrest. 1996. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by up-regulating BCL-2 levels. Exp. Cell Res. 224:335-343.
50. Takahashi, Y. 1992. Gene expression in cells of the central nervous system. Prog. Neurobiol. (NY). 38:523-569.
51. Gall, C.M., and P.J. Isackson. 1989. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science (Wash. DC). 245:758-761.
52. Larkfors, L., T. Ebendal, S.R. Whittemore, H. Persson, B. Hoffer, and L. Olson. 1987. Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Brain Res. 427:55-60.
53. Shi, D.Y., Z. Huaijie, J. Fu, S.F. Yan, A. Roher, W.W. Tourtellotte, T. Rajavashisth, X. Chen, G.C. Godman, D. Stern, and A.M. Schmidt. 1997. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:5296-5301.
54. Yan, S.D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (Lond.). 382:685-691.
55. Khoury, J.E., S.E. Hickman, C.A. Thomas, L. Cao, S.C. Silverstein, and J.D. Loike. 1996. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature (Lond.). 382:716-719.
56. Paresce, D.M., R.N. Ghosh, and F.R. Maxfield. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron. 17:553-565.
57. Yankner, B.A., A. Caceres, and L.K. Duffy. 1990. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc. Natl. Acad. Sci. USA. 87: 9020-9023.
58. Benedetti, M., A. Levi, and M.V. Chao. 1993. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Natl. Acad. Sci. USA. 90:7859-7863.